Science Daily - Heart Disease

MARCH 28, 2024

Young to middle-aged women who reported drinking eight or more alcoholic beverages per week--more than one per day, on average--were significantly more likely to develop coronary heart disease compared with those who drank less, finds a study presented at the American College of Cardiology's Annual Scientific Session. The risk was highest among both men and women who reported heavy episodic drinking, or 'binge' drinking, and the link between alcohol and heart disease appears to be especially str

Heart Disease 131

Heart Disease 131

Med Page Today

MARCH 28, 2024

(MedPage Today) -- Human brains appeared to be getting bigger, temporal trends showed. From the 1930s to 1970s, brain volumes and cortical surface area of people who had neither dementia nor stroke became progressively larger, reported Charles.

Dementia 133

Dementia Stroke Strokes 133

Dr. Smith's ECG Blog

MARCH 28, 2024

A 69 y.o. male with pertinent past medical history including Atrial fibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. Per EMS report, patient believes he has been in atrial fibrillation for 5 days, since coming down with flu-like illness with rhinorrhea, productive cough, SOB.

Tachycardia 127

Tachycardia Atrial Fibrillation AFIB Atrial Flutter 127

Science Daily - Heart Disease

MARCH 28, 2024

Whether you like your eggs sunny-side up, hard boiled or scrambled, many hesitate to eat them amid concerns that eggs may raise cholesterol levels and be bad for heart health. However, results from a prospective, controlled trial show that over a four-month period cholesterol levels were similar among people who ate fortified eggs most days of the week compared with those who didn't eat eggs.

Cholesterol 126

Cholesterol 126

Science Daily - Stroke

MARCH 28, 2024

A stroke often impacts a person's ability to move their lower body from the hips down to the feet. This leads to diminished quality of life and mental health in addition to increased susceptibility to falls. But now, researchers are exploring new treatment methods to help bridge the service delivery gap, and recovery outcomes, for patients after a stroke.

Quality of Life 106

Quality of Life Stroke Strokes Research 106

Science Daily - Heart Disease

MARCH 28, 2024

Younger women are generally thought to have a low risk of heart disease, but new research urges clinicians to revisit that assumption, especially for women who suffer from certain mental health conditions. A new study found that having anxiety or depression could accelerate the development of cardiovascular risk factors among young and middle-aged women.

Risk Factors 114

Risk Factors Heart Disease Research 114

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.

TAVR 104

TAVR Stenosis Aortic Aortic valve 104

Medical Xpress - Cardiology

MARCH 28, 2024

Magnesium is a mineral critical to a wide range of biological functions, and a new study takes aim at how it's transported to address cardiac dysfunction and other diseases, opening new possibilities for treatment.

Cardiac Function 108

Cardiac Function Research 108

Science Daily - Heart Disease

MARCH 28, 2024

Researchers have studied hundreds of elements of the built environment, including buildings, green spaces, pavements and roads, and how these elements relate to each other and influence coronary artery disease in people living in these neighborhoods. Their findings show that these factors can predict 63% of the variation in the risk of coronary heart disease from one area to another.

Cardiovascular Disease 87

Cardiovascular Disease Coronary Artery Disease Heart Disease Research 87

Medical Xpress - Cardiology

MARCH 28, 2024

There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg.

Diabetes 94

Diabetes Heart Attack Heart attacks Research 94

Med Page Today

MARCH 28, 2024

(MedPage Today) -- In this video, Mikhail Varshavski, DO -- who goes by "Dr. Mike" on social media -- gives a history lesson on the heart, including cultural depictions and the evolution of our understanding of anatomy. Following is a.

Anatomy 80

Anatomy 80

Cardiovascular Diabetology

MARCH 28, 2024

Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate in humans whether epigenetic signals involved in immune cell activatio.

Diabetes 80

Diabetes Atherosclerosis Research 80

HCPLive

MARCH 28, 2024

In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.

Diabetes 72

Diabetes 72

Becker's Hospital Review - Cardiology

MARCH 28, 2024

Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder are 57% more likely to develop cardiomyopathy after eight years compared to those not on stimulants, a new study found.

Cardiomyopathy 64

Cardiomyopathy 64

HCPLive

MARCH 28, 2024

The investigators seek to replicate the data in a future randomized control trial, and they hope to compare biofeedback to different therapies such as pulmonary rehabilitation.

Pulmonary 69

Pulmonary 69

American College of Cardiology

MARCH 28, 2024

The following are key points to remember from a state-of-the-art review on the evolving concept of secondary mitral regurgitation (MR) phenotypes and lessons from the mitral transcatheter edge-to-edge repair (M-TEER) trials.

Bicuspid/Mitral 67

Bicuspid/Mitral Article 67

HCPLive

MARCH 28, 2024

The recent rise in colorectal cancer incidence and mortality in younger patients has sparked a serious discussion about strategies to increase screening uptake and adherence, raising questions about the role of noninvasive tests versus the traditional “gold standard,” colonoscopy.

Cancer 69

Cancer 69

Cardiovascular Diabetology

MARCH 28, 2024

Coronary inflammation plays crucial role in type 2 diabetes mellitus (T2DM) induced cardiovascular complications. Both glucose-lowering drug interventions (GLDIS) and glycemic control (GC) status potentially c.

Diabetes 59

Diabetes Research 59

HCPLive

MARCH 28, 2024

The first quarterly issue of 2024 reviews a promising JAK inhibitor for acute severe ulcerative colitis, fenofibrates in PBC, new recommendations from the AGA, and a next generation multi-target DNA stool test for detecting colorectal cancer.

Cancer 59

Cancer 59

American College of Cardiology

MARCH 28, 2024

What is the performance of an artificial intelligence (AI)-derived risk score in predicting 1-year outcomes of patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge repair (TEER)?

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Article 52

HCPLive

MARCH 28, 2024

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

59

59

Medical Xpress - Cardiology

MARCH 28, 2024

In a Leicester study that looked at whether artificial intelligence (AI) can be used to predict whether a pe 100 29351 0 29351 0 0 258k 0 --:--:-- --:--:-- --:--:-- 260k rson was at risk of a lethal heart rhythm, an AI tool correctly identified the condition 80% of the time.

Heart Rhythm 50

Heart Rhythm 50

HCPLive

MARCH 28, 2024

In part 2 of our 5-part discussion, experts discuss challenges they face getting patients to engage in screening and how to effectively discuss screening with patients.

Cancer 59

Cancer 59

American College of Cardiology

MARCH 28, 2024

For patients on the heart transplant waiting list, what association does race and gender have with the probability of donor heart offers being accepted?

Transplant 52

Transplant Heart Transplant Article 52

HCPLive

MARCH 28, 2024

Kenneth Saag, MD, explores the clinical significance of a study demonstrating treatment with pegloticase leads to bone remodeling in patients with gout.

59

59

Circulation

MARCH 28, 2024

Circulation, Ahead of Print. Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health. Despite substantial technologic advances in recent years, issues with hardware design, data analysis, and integration into the clinical workflow prevent wearables from reaching their potential in high-risk congenital heart disea

Congenital Heart Disease 45

Congenital Heart Disease Congenital Heart Disease Pediatrics 45

HCPLive

MARCH 28, 2024

In part 3 of our 5-part discussion, experts discuss the importance of screening among younger patient populations and strategies to encourage screening in patient populations susceptible to nonadherence.

Cancer 52

Cancer 52

Medical Xpress - Cardiology

MARCH 28, 2024

Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels and is a leading cause of death globally. Lifestyle factors have been linked to the incidence of CVD and the inclusion of an active, healthy lifestyle along with other therapeutic interventions may help combat CVD.

Cardiovascular Disease 40

Cardiovascular Disease 40

HCPLive

MARCH 28, 2024

An expert retina specialist discusses challenges faced by DME patients showing suboptimal response to standard anti-VEGF treatment, emphasizing the need to reduce injection burden while preventing vision loss.

52

52

NEJM Journal Watch - Cardiology

MARCH 28, 2024

In a retrospective study, patients with markedly elevated aortic gradients had similarly poor prognosis regardless of whether estimated valve area was severely or moderately reduced.

Aortic 40

Aortic Stenosis 40

HCPLive

MARCH 28, 2024

Ehsan Rahimy, MD, outlines strategies for managing cases of high-risk PDR and DME, exploring new therapies and synergistic combinations with anti-VEGF and steroids for longer-lasting responses.

52

52

Cassling

MARCH 28, 2024

Industry’s strongest gradients on a clinically available 3T MR scanner Enables clinicians to see smaller structures and capture images faster New features address major obstacles for scientific community, can advance research Siemens Healthineers has announced the Food and Drug Administration clearance of the MAGNETOM Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner.

Cancer 52

Cancer Research Blog 52

HCPLive

MARCH 28, 2024

Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai discuss VISIBLE trial, a randomized clinical trial specifically designed to examine treatment outcomes with guselkumab in patients with skin of color.

Outcomes 52

Outcomes 52

The American Journal of Cardiology

MARCH 28, 2024

Publication date: Available online 27 March 2024 Source: The American Journal of Cardiology Author(s): Giampaolo Niccoli, Filippo Luca Gurgoglione

40

40

HCPLive

MARCH 28, 2024

Ehsan Rahimy, MD, discusses challenges in managing longstanding nAMD patients rotating through anti-VEGF treatments, highlighting the promise of newer therapies like aflibercept 8mg and faricimab.

52

52

Stroke Journal

MARCH 28, 2024

Stroke, Ahead of Print.

Stroke 75

Stroke Strokes 75

HCPLive

MARCH 28, 2024

The first-in-human trial of VRON-0200, a novel immunotherapy for chronic hepatitis B virus, presented at the APSAL meeting, demonstrates a promising safety and tolerability profile.

52

52